Being Principal Investigators on Pharma-initiated Clinical Trials: Have we Sold Ourselves Too Cheap?
Journal Title: UNKNOWN - Year 2017, Vol 7, Issue 1
Abstract
The other day in clinic I was going through one of those good-clinical-practice (GCP) modules, as requested by one of the pharma companies in order for me to participate as an investigator in one of their clinical trial. As I repetitively wasn't able to correctly answer the minimum 80% of the questions needed for me to pass the final test of the module, my morning hours just flew by, and with my increasing level of anxiety, it suddenly dawned on me-we, physician-investigators participating in pharma-initiated clinical trials, have sold ourselves too cheap.
Authors and Affiliations
Leibowitz-Amit R
Keywords
Related Articles
- EP ID EP382344
- DOI 10.4172/2167-0870.1000295
- Views 43
- Downloads 0
Being Principal Investigators on Pharma-initiated Clinical Trials: Have we Sold Ourselves Too Cheap?
The other day in clinic I was going through one of those good-clinical-practice (GCP) modules, as requested by one of the pharma companies in order for me to participate as an investigator in one of their clinical trial....
Toward a Comprehensive and Accurate Measure of Clinical Trial Workload, Equity, Quality Assurance and Patient Safety-How Much Workload is Too Much? Commentary and Brief Research Report
This article provides a brief commentary on the methodology surrounding controlled clinical trials, the growing trend of centers conducting multiple controlled trials (i.e. “factory science”), trial workload measures, an...
Implant-type Tissue-engineered Cartilage for Secondary Correction of Cleft Lip-nose Patients: An Exploratory First-in-human Trial
Objective: Secondary correction of cleft lip-nose presents a formidable challenge in cleft lip and palate surgery. Although numerous approaches have been proposed, suitable graft materials cannot be obtained from any par...
Hierarchical Agglomerative Cluster Analysis as a Trial Method Revealing Developmental Coordination Disorder (DCD) Subtypes
Background: There is increasing evidence that children with DCD have been classified into distinguishable ‘subtypes’ mainly based on perceptual-motor, fine and gross motor skills. Previous research efforts define and des...
Keratosis Lesion on the Nose
Porokeratosis (PK) is a rare skin disease, of unknown etiology, probably due to a disorder of epidermal keratinization. We describe a 24 year-old male patient, with porokeratosis of Mibelli confirmed histopathologically....